Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Embera's phase I study of EMB-001 to receive funding from Sounds Affects Life

July 4, 2014

Japanese researchers present radiation-induced injury treatments

June 27, 2014

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

June 25, 2014

Bunavail buccal film approved by FDA for opioid dependence

June 11, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Double-blind trial finds (S)-(-)-OSU-6162 effective in treating alcohol dependence

May 9, 2014

FDA approves Evzio for the emergency treatment of opioid overdose

April 7, 2014

Medesis Pharma and CEA sign collaborative agreement

April 3, 2014

Southwest Research Institute receives contract extension for cyanide antidote

March 31, 2014

New monoclonal antibodies for the treatment of botulism disclosed

March 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...